Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a home sugar test replace the clinic visit for diabetes diagnosis?

NCT ID NCT06862128

Diagnosis Sponsor: Linkoeping University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times

Summary

This study compares a self-administered oral glucose tolerance test (OGTT) at home using a continuous glucose monitor (CGM) with the standard clinic-based OGTT. 75 adults with prediabetes will undergo both tests to see if the home version accurately diagnoses blood sugar problems. The goal is to make testing more convenient and accessible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

70 people

The number who actually took part.

Started

Jun 2025

Expected to finish

Dec 2040

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Prediabetes indicated by any of the following values: * \- Fasting venous plasma glucose ≥5.6 but \<7.0 mmol/L * \- HbA1c ≥39 but \<48 mmol/mol * Access to a smart phone which is compatible with the CGM application and has working Bluetooth connectivity * Ability to read and respond to online instructions and questionnaires in Swedish. Exclusion Criteria: * T2D indicated by ≥2 of the following values, measured at different occasions or through different analyses: * \- Fasting venous plasma glucose ≥7.0 mmol/L * \- Non-fasting venous plasma glucose value ≥11.1 mmol/L * \- HbA1c ≥48 mmol/mol * Previous bariatric surgery e.g., gastric by-pass or gastric sleeve surgery * Body mass index \<20 kg/m2 * Body weight \<43 kg * Current pregnancy * Need of regular use of GLP-1 receptor agonists, SGLT-2 inhibitors, acetaminophen or ascorbic acid supplements during the study period * Fear of needle sticks * Shift work during the study period * Involvement in the study design, data collection, analysis, or participant recruitment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetes mellitus glucose intolerance prediabetes syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes Pre-diabetes

Contacts and locations

Locations

  • Primary Care Center Vårdcentralen Kärna

    Linköping, Östergötland County, 58662, Sweden

  • Primary Health Care Center Bra Liv Rosenhälsan

    Huskvarna, Jönköping County, 55185, Sweden

  • Primary Health Care Center Cityhälsan Centrum

    Norrköping, Norrköping, 60239, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.